Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma.
Illidge T, Chan C, Counsell N, Morris S, Scarisbrick J, Gilson D, Popova B, Patrick P, Smith P, Whittaker S, Cowan R.
Illidge T, et al. Among authors: smith p.
Br J Cancer. 2013 Nov 12;109(10):2566-73. doi: 10.1038/bjc.2013.616. Epub 2013 Oct 17.
Br J Cancer. 2013.
PMID: 24136145
Free PMC article.
Clinical Trial.